{"name": "Sapheon",
 "permalink": "sapheon",
 "crunchbase_url": "http://www.crunchbase.com/company/sapheon",
 "homepage_url": "http://www.sapheoninc.com",
 "blog_url": "http://sapheoninc.com/blog/",
 "blog_feed_url": "",
 "twitter_username": "Sapheon1",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Sat Aug 25 03:04:15 UTC 2012",
 "updated_at": "Fri Apr 05 04:59:20 UTC 2013",
 "overview": "\u003Cp\u003ESapheon is a medical device company whose mission is to develop new approaches and disruptive technologies for the treatment of vascular disease.\u003C/p\u003E\n\n\u003Cp\u003ESapheon Inc. is a medical device company whose mission is to develop new approaches and disruptive technologies for the treatment of vascular disease.\u003C/p\u003E\n\n\u003Cp\u003EThe company\u2019s current focus is the VenaSeal Sapheon Closure System, a novel treatment for venous reflux disease. With full EU regulatory approval already in place, this game-changing approach to treating veins is poised to disrupt a $1 billion worldwide market.\u003C/p\u003E\n\n\u003Cp\u003EThe VenaSeal System uses a proprietary medical adhesive to close the saphenous vein, eliminating the need for surgery, ablation, anesthesia, or the use of harsh chemicals. Sapheon is actively preparing for U.S. clinical trials and FDA approval of the VenaSeal Sapheon Closure System.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       64],
      "assets/images/resized/0020/8083/208083v1-max-150x150.jpg"],
     [[209,
       90],
      "assets/images/resized/0020/8083/208083v1-max-250x250.jpg"],
     [[209,
       90],
      "assets/images/resized/0020/8083/208083v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$8.6M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.finsmes.com/2012/08/sapheon-completes-8-6m-closing-series-equity-funding.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Sapheon Completes $8.6M First Closing of Series B Equity Funding",
    "raised_amount": 8600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 8,
    "funded_day": 24,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Millennium Life Sciences Fund",
         "permalink": "millennium-life-sciences-fund",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "3579 Westwind Blvd.",
    "address2": "",
    "zip_code": "95403",
    "city": "Santa Rosa",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        113],
       "assets/images/resized/0020/8084/208084v1-max-150x150.jpg"],
      [[250,
        189],
       "assets/images/resized/0020/8084/208084v1-max-250x250.jpg"],
      [[450,
        341],
       "assets/images/resized/0020/8084/208084v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}